StockMacro
Menu

Centene

$63.78 +11% in 6 monthsMarket cap $31.6B

CNC on XNYS, Financials, Centene Corporation, job postings

Measures activity, not value. Not investment advice.

Shares up 83% in 12 months but down 9.2% in one month as institutional count rose 8.0%.

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

Industry
Hospital & medical service plans (Financials)
Employees
61,100
Website
centene.com
Listed
NYSE, US
Last results
26 Oct 2026
Next results
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $50.6B, net loss $71.0M.
Quarter to 31 Dec 2021: revenue $32.6B, net income $599.0MQuarter to 31 Dec 2021: revenue $32.6B, net income $599.0MQuarter to 31 Mar 2022: revenue $37.2B, net income $849.0MQuarter to 31 Mar 2022: revenue $37.2B, net income $849.0MQuarter to 30 Jun 2022: revenue $35.9B, net income -$172.0MQuarter to 30 Jun 2022: revenue $35.9B, net income -$172.0MQuarter to 30 Sep 2022: revenue $35.9B, net income $738.0MQuarter to 30 Sep 2022: revenue $35.9B, net income $738.0MQuarter to 31 Dec 2022: revenue $35.6B, net income -$213.0MQuarter to 31 Dec 2022: revenue $35.6B, net income -$213.0MQuarter to 31 Mar 2023: revenue $38.9B, net income $1.1BQuarter to 31 Mar 2023: revenue $38.9B, net income $1.1BQuarter to 30 Jun 2023: revenue $37.6B, net income $1.1BQuarter to 30 Jun 2023: revenue $37.6B, net income $1.1BQuarter to 30 Sep 2023: revenue $38.0B, net income $469.0MQuarter to 30 Sep 2023: revenue $38.0B, net income $469.0MQuarter to 31 Dec 2023: revenue $39.5B, net income $45.0MQuarter to 31 Dec 2023: revenue $39.5B, net income $45.0MQuarter to 31 Mar 2024: revenue $40.4B, net income $1.2BQuarter to 31 Mar 2024: revenue $40.4B, net income $1.2BQuarter to 30 Jun 2024: revenue $39.8B, net income $1.1BQuarter to 30 Jun 2024: revenue $39.8B, net income $1.1BQuarter to 30 Sep 2024: revenue $42.0B, net income $713.0MQuarter to 30 Sep 2024: revenue $42.0B, net income $713.0MQuarter to 31 Dec 2024: revenue $40.8B, net income $283.0MQuarter to 31 Dec 2024: revenue $40.8B, net income $283.0MQuarter to 31 Mar 2025: revenue $46.6B, net income $1.3BQuarter to 31 Mar 2025: revenue $46.6B, net income $1.3BQuarter to 30 Jun 2025: revenue $48.7B, net income -$253.0MQuarter to 30 Jun 2025: revenue $48.7B, net income -$253.0MQuarter to 30 Sep 2025: revenue $49.7B, net income -$6.6BQuarter to 30 Sep 2025: revenue $49.7B, net income -$6.6BQuarter to 31 Dec 2025: revenue $49.7B, net income -$1.1BQuarter to 31 Dec 2025: revenue $49.7B, net income -$1.1BQuarter to 31 Mar 2026: revenue $49.9B, net income $1.5BQuarter to 31 Mar 2026: revenue $49.9B, net income $1.5BQuarter to 30 Jun 2026: revenue $53.6B, net income $1.1BQuarter to 30 Jun 2026: revenue $53.6B, net income $1.1BQuarter to 30 Sep 2026: revenue $50.6B, net income -$71.0MQuarter to 30 Sep 2026: revenue $50.6B, net income -$71.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $53.6B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$50.6B-$71.0M
30 Jun 2026$53.6B$1.1B
31 Mar 2026$49.9B$1.5B
31 Dec 2025$49.7B-$1.1B
30 Sep 2025$49.7B-$6.6B
30 Jun 2025$48.7B-$253.0M
31 Mar 2025$46.6B$1.3B
31 Dec 2024$40.8B$283.0M
30 Sep 2024$42.0B$713.0M
30 Jun 2024$39.8B$1.1B
31 Mar 2024$40.4B$1.2B
31 Dec 2023$39.5B$45.0M
30 Sep 2023$38.0B$469.0M
30 Jun 2023$37.6B$1.1B
31 Mar 2023$38.9B$1.1B
31 Dec 2022$35.6B-$213.0M
30 Sep 2022$35.9B$738.0M
30 Jun 2022$35.9B-$172.0M
31 Mar 2022$37.2B$849.0M
31 Dec 2021$32.6B$599.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $1.5B -$5.3B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $2.92 -$10.76
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 20.7%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – 1.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – 1.7%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 6.8% 9.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $3.9B $3.4B
CashCash, cash equivalents and short-term investments on the latest balance sheet. – –
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. –
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $44.86
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 21.6 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 0.42
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. –
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.4 2.7

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small. Cash, debt and EV/Sales are not shown for banks, insurers and investment companies.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CenteneCNC (this company) $31.6B21.6–––
HumanaHUM $46.8B37.60.30+22%0.8%
CignaCI $71.4B11.90.25+6.8%2.1%
Elevance HealthELV $85.2B16.60.42+3.6%2.5%
Molina HealthcareMOH $10.4Bloss0.23-0.9%-0.1%
Oscar HealthOSCR $7.7B9.00.44+55%4.9%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$3.8M

bought $0, sold $3.8M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+8.0%

1,064 13F filers vs 985

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

98%

483.6M shares held by 13F filers (30 Sep 2026) of 495.1M outstanding (23 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.1%

10.5M shares sold short (30 Oct 2026) of 495.1M outstanding (23 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.0

10.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.9%

10.9M shares sold short in the report before, 10.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

43%

43% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 40%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-21%

92 vs 116 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+1.9%

$50.6B vs $49.7B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-8.1%

$194.0M vs $211.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$235.2M

the 12 months before: $80K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$4.8M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

33

33 articles in the last 7 days; its usual week has 7 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4.7×

33 articles in the last 7 days; its usual week has 7.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New agency award $3.0M, first

Price $63.78 on 20 Nov 2026, +83% over 12 months (12-month range $31.80 to $76.01)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $14.6M in the last 12 months (the 12 months before: $2.8M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 91 published in the last 12 months, -21% on the 12 months before.
Revenue per quarter. Revenue $50.6B in the latest quarter, +1.9% on a year earlier.
Capital spending per quarter. Capital spending $194.0M in the latest quarter, -8.1% on a year earlier.
Institutional holders (13F filers). 1,064 13F filers reported holding it in the latest 13F quarter, +33% on a year earlier.
Federal obligations. Federal obligations: $194.2M published in the last 12 months, +1754109% on the 12 months before.
Lobbying spend. Lobbying spend: $4.8M published in the last 12 months, +27% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 Oct 2026Sharp changeFirst award from a new federal agency: first award from a new federal agency (Department of Defense): MAGELLAN FEDERAL, INC.: new Department of Defense contract HQ003426FE315 ($3,024,811)
17 Aug 20268-K and other filingsDirector or officer change
6 Aug 2026Sharp changeFederal obligations jump: federal obligations jump, 33.2M vs usual 861K in the same month of earlier years (2026-07-01..2026-07-31)
27 Jul 20268-K and other filingsDirector or officer change
22 Jun 20268-K and other filingsDirector or officer change
9 Jun 2026Sharp changeFederal obligations jump: federal obligations jump, 40.0M vs usual 538K in the same month of earlier years (2026-05-01..2026-05-31); -998.3x the same month a year earlier
15 May 20268-K and other filingsDirector or officer change
7 May 2026Sharp changeFederal obligations jump: federal obligations jump, 101.9M vs usual 0 in the same month of earlier years (2026-04-01..2026-04-30)
7 Apr 2026Lobbying filinglobbying engagement terminated (SALT POINT STRATEGIES)
30 Mar 2026Sharp changeFirst award from a new federal agency: first award from a new federal agency (Department of Health and Human Services): MAGELLAN FEDERAL, INC.: new Department of Health and Human Services contract 7571MN26F66003 ($13,200,561)
24 Mar 20268-K and other filingsDirector or officer change
24 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Sep 2025Sharp changeShort interest spike: short interest spike, 23.7M vs usual 9.8M (2025-08-15); 2.4x the same period a year earlier
15 Aug 20258-K and other filingsDirector or officer change
12 Aug 2025Sharp changeShort interest spike: short interest spike, 27.8M vs usual 9.8M (2025-07-31); 2.7x the same period a year earlier
4 Aug 20258-K and other filingsDirector or officer change
4 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Jul 2025Sharp changeWikipedia attention spike: wikipedia attention spike, 5,998 vs usual 1,562 (2025-06-30..2025-07-06); 4.8x the same week a year earlier
5 Mar 20258-K and other filingsA major agreement ended
28 Feb 2025Lobbying filingnew lobbying registration (ALB SOLUTIONS)
24 Feb 20258-K and other filingsDirector or officer change
24 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Feb 2025Lobbying filingnew lobbying registration (SALT POINT STRATEGIES)
27 Jan 2025Lobbying filingnew lobbying registration (WILLIAMS AND JENSEN, PLLC)
21 Jan 2025Lobbying filinglobbying engagement terminated (CORNERSTONE GOVERNMENT AFFAIRS, INC.)
17 Jan 2025Lobbying filinglobbying engagement terminated (GREENBERG TRAURIG, LLP)
17 Jan 2025Lobbying filingnew lobbying registration (CONTINENTAL STRATEGY, LLC)
18 Dec 2024Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 1.0M)
10 Dec 2024Sharp changeWikipedia attention spike: wikipedia attention spike, 5,236 vs usual 1,769 (2024-12-02..2024-12-08); 2.7x the same week a year earlier
12 Nov 2024Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 24 vs usual 5.50 in the same month of earlier years (2024-09-01..2024-09-30); 3.4x the same month a year earlier
12 Nov 20248-K and other filingsDirector or officer change
17 Oct 2024Lobbying filinglobbying engagement terminated (HSA STRATEGIES)
1 Oct 2024Lobbying filinglobbying engagement terminated (BRYAN CAVE LEIGHTON PAISNER LLP)
27 Sep 20248-K and other filingsDirector or officer change
15 Aug 20248-K and other filingsDirector or officer change
15 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 2024Sharp changeShort interest spike: short interest spike, 13.5M vs usual 7.2M (2024-07-15); 2.0x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 13.7M vs usual 7.1M (2024-06-28); 2.1x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 12.7M vs usual 7.0M (2024-06-14); 2.0x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 13.1M vs usual 7.0M (2024-05-31); 1.8x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 9.6M vs usual 6.8M (2024-03-15); 1.4x the same period a year earlier
29 Mar 20248-K and other filingsDirector or officer change
29 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jan 2024Lobbying filinglobbying engagement terminated (HEALTH POLICY SOURCE, INC.)
15 Nov 20238-K and other filingsDirector or officer change
15 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 May 20238-K and other filingsDirector or officer change
22 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Feb 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 1.5M)
20 Jan 2023Sharp changeLobbying on a new issue: lobbying on a new issue: DEF (2022-12-31)
14 Dec 20228-K and other filingsDirector or officer change
16 Nov 20228-K and other filingsDirector or officer change
16 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Oct 2022Lobbying filinglobbying engagement terminated (HEALTHSPERIEN)
17 Jun 20228-K and other filingsAsset write-down (impairment)
4 May 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 1.7M)
2 May 20228-K and other filingsDirector or officer change
21 Apr 2022Sharp changeLobbying on a new issue: lobbying on a new issue: INS (2022-03-31)
20 Apr 2022Lobbying filinglobbying engagement terminated (WILEY REIN LLP)
19 Apr 2022Lobbying filinglobbying engagement terminated (MASON STREET CONSULTING, LLC)
15 Apr 20228-K and other filingsDirector or officer change
6 Apr 2022Lobbying filingnew lobbying registration (HSA STRATEGIES)
22 Mar 20228-K and other filingsDirector or officer change
24 Feb 20228-K and other filingsDirector or officer change
19 Jan 2022Lobbying filinglobbying engagement terminated (COZEN O'CONNOR PUBLIC STRATEGIES)
11 Jan 20228-K and other filingsDirector or officer change
4 Jan 20228-K and other filingsCompleted an acquisition or asset sale
14 Dec 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Dec 2021: -$5.5M published
Month from 1 Jan 2022: -$532K published
Month from 1 Mar 2022: -$305K published
Month from 1 May 2022: $1.1M published
Month from 1 Jun 2022: -$1.1M published
Month from 1 Jul 2022: -$394K published
Month from 1 Aug 2022: -$941K published
Month from 1 Feb 2023: $1.5M published
Month from 1 Mar 2023: $1.9M published
Month from 1 Apr 2023: -$93K published
Month from 1 Feb 2024: -$1.7M published
Month from 1 May 2024: -$688K published
Month from 1 Nov 2024: $1.3M published
Month from 1 Dec 2024: $2.0M published
Month from 1 Jul 2025: $249K published
Month from 1 Aug 2025: $490K published
Month from 1 Dec 2025: -$2.6M published
Month from 1 Jun 2026: -$5.2M published
Month from 1 Aug 2026: -$6.9M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 29 published
Quarter from 1 Apr 2022: 26 published
Quarter from 1 Jul 2022: 32 published
Quarter from 1 Oct 2022: 33 published
Quarter from 1 Jan 2023: 26 published
Quarter from 1 Apr 2023: 30 published
Quarter from 1 Jul 2023: 34 published
Quarter from 1 Oct 2023: 33 published
Quarter from 1 Jan 2024: 17 published
Quarter from 1 Apr 2024: 27 published
Quarter from 1 Jul 2024: 33 published
Quarter from 1 Oct 2024: 48 published
Quarter from 1 Jan 2025: 41 published
Quarter from 1 Apr 2025: 19 published
Quarter from 1 Jul 2025: 27 published
Quarter from 1 Oct 2025: 28 published
Quarter from 1 Jan 2026: 16 published
Quarter from 1 Apr 2026: 26 published
Quarter from 1 Jul 2026: 27 published
Quarter from 1 Oct 2026: 22 published
Revenue per quarter
Quarter ended 31 Dec 2021: $32.6B, +15% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $37.2B, +24% on a year earlier; public on 27 Apr 2022
Quarter ended 30 Jun 2022: $35.9B, +16% on a year earlier; public on 27 Jul 2022
Quarter ended 30 Sep 2022: $35.9B, +11% on a year earlier; public on 26 Oct 2022
Quarter ended 31 Dec 2022: $35.6B, +9.2% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $38.9B, +4.6% on a year earlier; public on 26 Apr 2023
Quarter ended 30 Jun 2023: $37.6B, +4.7% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $38.0B, +6.1% on a year earlier; public on 25 Oct 2023
Quarter ended 31 Dec 2023: $39.5B, +11% on a year earlier; public on 21 Feb 2024
Quarter ended 31 Mar 2024: $40.4B, +3.9% on a year earlier; public on 27 Apr 2024
Quarter ended 30 Jun 2024: $39.8B, +5.9% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $42.0B, +10% on a year earlier; public on 26 Oct 2024
Quarter ended 31 Dec 2024: $40.8B, +3.4% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $46.6B, +15% on a year earlier; public on 26 Apr 2025
Quarter ended 30 Jun 2025: $48.7B, +22% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $49.7B, +18% on a year earlier; public on 30 Oct 2025
Quarter ended 31 Dec 2025: $49.7B, +22% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $49.9B, +7.1% on a year earlier; public on 29 Apr 2026
Quarter ended 30 Jun 2026: $53.6B, +9.9% on a year earlier; public on 29 Jul 2026
Quarter ended 30 Sep 2026: $50.6B, +1.9% on a year earlier; public on 28 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $248.0M, +20% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $242.0M, +29% on a year earlier; public on 27 Apr 2022
Quarter ended 30 Jun 2022: $282.0M, +13% on a year earlier; public on 27 Jul 2022
Quarter ended 30 Sep 2022: $247.0M, +9.8% on a year earlier; public on 26 Oct 2022
Quarter ended 31 Dec 2022: $233.0M, -6.0% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $225.0M, -7.0% on a year earlier; public on 26 Apr 2023
Quarter ended 30 Jun 2023: $215.0M, -24% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $136.0M, -45% on a year earlier; public on 25 Oct 2023
Quarter ended 31 Dec 2023: $223.0M, -4.3% on a year earlier; public on 21 Feb 2024
Quarter ended 31 Mar 2024: $151.0M, -33% on a year earlier; public on 27 Apr 2024
Quarter ended 30 Jun 2024: $186.0M, -13% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $153.0M, +12% on a year earlier; public on 26 Oct 2024
Quarter ended 31 Dec 2024: $154.0M, -31% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $135.0M, -11% on a year earlier; public on 26 Apr 2025
Quarter ended 30 Jun 2025: $208.0M, +12% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $211.0M, +38% on a year earlier; public on 30 Oct 2025
Quarter ended 31 Dec 2025: $213.0M, +38% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $200.0M, +48% on a year earlier; public on 29 Apr 2026
Quarter ended 30 Jun 2026: $174.0M, -16% on a year earlier; public on 29 Jul 2026
Quarter ended 30 Sep 2026: $194.0M, -8.1% on a year earlier; public on 28 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 727; public on 14 Feb 2022
31 Mar 2022 report: 775; public on 16 May 2022
30 Jun 2022 report: 782; public on 15 Aug 2022
30 Sep 2022 report: 762; public on 14 Nov 2022
31 Dec 2022 report: 795; public on 14 Feb 2023
31 Mar 2023 report: 795; public on 15 May 2023
30 Jun 2023 report: 765; public on 14 Aug 2023
30 Sep 2023 report: 748; public on 14 Nov 2023
31 Dec 2023 report: 834; public on 14 Feb 2024
31 Mar 2024 report: 885; public on 15 May 2024
30 Jun 2024 report: 845; public on 14 Aug 2024
30 Sep 2024 report: 828; public on 14 Nov 2024
31 Dec 2024 report: 825; public on 14 Feb 2025
31 Mar 2025 report: 854; public on 15 May 2025
30 Jun 2025 report: 834; public on 14 Aug 2025
30 Sep 2025 report: 800; public on 14 Nov 2025
31 Dec 2025 report: 867; public on 17 Feb 2026
31 Mar 2026 report: 841; public on 15 May 2026
30 Jun 2026 report: 985; public on 14 Aug 2026
30 Sep 2026 report: 1,064; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $0 published
Month from 1 Dec 2021: $161.7M published
Month from 1 Jan 2022: $550.7M published
Month from 1 Feb 2022: $1.8M published
Month from 1 Mar 2022: $827.6M published
Month from 1 Apr 2022: $6.9M published
Month from 1 May 2022: $444.2M published
Month from 1 Jun 2022: $14.5M published
Month from 1 Jul 2022: $1.4B published
Month from 1 Aug 2022: $538K published
Month from 1 Sep 2022: $21.8M published
Month from 1 Oct 2022: $30.1M published
Month from 1 Nov 2022: $255.1M published
Month from 1 Dec 2022: $49.0M published
Month from 1 Jan 2023: $562.0M published
Month from 1 Feb 2023: $117.7M published
Month from 1 Mar 2023: $470.6M published
Month from 1 Apr 2023: $394.3M published
Month from 1 May 2023: $1.2B published
Month from 1 Jun 2023: -$15.0M published
Month from 1 Jul 2023: $37.1M published
Month from 1 Aug 2023: $6.1M published
Month from 1 Sep 2023: $583.1M published
Month from 1 Oct 2023: $820K published
Month from 1 Nov 2023: $120.7M published
Month from 1 Dec 2023: $161.2M published
Month from 1 Jan 2024: $470.2M published
Month from 1 Feb 2024: $569.4M published
Month from 1 Apr 2024: $84K published
Month from 1 Aug 2024: $14K published
Month from 1 Sep 2024: $14K published
Month from 1 Oct 2024: $29K published
Month from 1 Nov 2024: $11K published
Month from 1 Jan 2025: $51K published
Month from 1 May 2025: -$40K published
Month from 1 Feb 2026: -$20K published
Month from 1 Mar 2026: $38.3M published
Month from 1 Apr 2026: -$2.4M published
Month from 1 May 2026: $148.3M published
Month from 1 Jun 2026: $459K published
Month from 1 Jul 2026: $48.0M published
Month from 1 Aug 2026: -$41.7M published
Month from 1 Sep 2026: -$345K published
Month from 1 Oct 2026: $3.6M published
Month from 1 Nov 2026: $14K published
Lobbying spend
Quarter from 1 Jan 2022: $1.4M published
Quarter from 1 Apr 2022: $1.1M published
Quarter from 1 Jul 2022: $1.1M published
Quarter from 1 Oct 2022: $1.1M published
Quarter from 1 Jan 2023: $1.5M published
Quarter from 1 Apr 2023: $1.6M published
Quarter from 1 Jul 2023: $1.2M published
Quarter from 1 Oct 2023: $1.2M published
Quarter from 1 Jan 2024: $1.0M published
Quarter from 1 Apr 2024: $1.4M published
Quarter from 1 Jul 2024: $1.4M published
Quarter from 1 Oct 2024: $920K published
Quarter from 1 Jan 2025: $620K published
Quarter from 1 Apr 2025: $890K published
Quarter from 1 Jul 2025: $1.5M published
Quarter from 1 Oct 2025: $740K published
Quarter from 1 Jan 2026: $1.1M published
Quarter from 1 Apr 2026: $1.1M published
Quarter from 1 Jul 2026: $1.5M published
Quarter from 1 Oct 2026: $1.1M published

What is unusual now

  • Made public in the last 90 days: it won its first award from the Department of Defense, a $3.0M contract, after 15 earlier federal awards from other agencies.
  • Federal obligations jump: booked $33.2M in federal contract and grant obligations in July 2026, against none in the same month last year Public on 30 Jul 2026.
  • First award from a new federal agency: won its first award from the Department of Defense, a $3.0M contract, after 15 earlier federal awards from other agencies Public on 9 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $14.6M in the last 12 months (the 12 months before: $2.8M).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $3.8M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
27 Aug 2026Christopher KosterSecretary & General CounselSell56,500$66.90$3.8MForm 4
19 Aug 2026Christopher KosterSecretary & General CounselSell47,603$65.36$3.1MForm 4
11 Jun 2026Kenneth A BurdickDirectorSell80,000$64.55$5.2MForm 4
5 Dec 2025Kenneth A BurdickDirectorSell66,007$39.02$2.6MForm 4
11 Aug 2025Sarah LondonChief Executive OfficerBuy19,230$25.50$490KForm 4
29 Jul 2025Theodore R. Samuels IIDirectorBuy9,000$27.62$249KForm 4
19 Dec 2024Thomas GrecoDirectorBuy17,000$59.75$1.0MForm 4
17 Dec 2024H James DallasDirectorBuy1,693$59.01$100KForm 4

1,064 institutions reported shares at the end of Q3 2026, 98% of the shares outstanding; 158 opened a position, 80 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.44.7M9.04%$2.8B+3.3M+8.0%
Vanguard Capital Management LLC32.3M6.53%$2.0B+853K+2.7%
AQR Capital Management LLC31.4M6.34%$1.9B+2.7M+9.5%
State Street Corp23.1M4.66%$1.4B+1.1M+5.1%
Vanguard Portfolio Management LLC22.5M4.54%$1.4B+128K+0.6%
Geode Capital Management, LLC14.1M2.85%$876.2M+812K+6.1%
Invesco Ltd.13.6M2.75%$845.3M+2.4M+22%
Ameriprise Financial Inc12.2M2.46%$755.5M-257K-2.1%
Victory Capital Management Inc10.9M2.21%$679.8M+5.1M+86%
Morgan Stanley10.0M2.01%$619.5M-79K-0.8%

Federal contracts

All 16 federal contracts

2 new awards in 12 months, $15.1M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
9 Jul 2026Department of DefenseWashington Headquarters Services$2.9Mup to $6.2MEMPLOYEE ASSISTANCE PROGRAMS (EAP) WORK-LIFE SERVICES-BRIDGEUSAspending
24 Mar 2026Department of Health and Human ServicesOffice of the Assistant Secretary for Financial Resources$12.2Mup to $21.6MEAP/WORKLIFE SERVICES TASK ORDER 3USAspending
3 Jun 2019Department of Veterans Affairs$84.5MTASK ORDER FUNDS THE SETTLEMENT ACTION FOR TWO COMBINED CONTRACTUAL CLAIMS--SETTLEMENT OF THE OPTION YEAR 4 CLAIM AND THE PARTIAL ADMIN FEE CLAIM AS REFERENCE IN THE SETTLEMENT AGREEMENT CONTAINED IN P0071 OF THE BASIC CONTRACTUSAspending
2 Oct 2018Department of Veterans Affairs$8.8MCONTRACT CLOSE OUT.USAspending
30 Sep 2018Department of Veterans Affairs$1.0MXX24A SERVICESUSAspending
30 Sep 2018Department of Veterans Affairs$401.4MEXPRESS REPORT: PCCC/CHOICEUSAspending
13 Jul 2018Department of the InteriorDepartmental Offices$31.3Mup to $243.5MMILITARY AND FAMILY LIFE COUNSELING PROGRAMUSAspending
1 Oct 2017Department of Veterans Affairs$216.8MEXPRESS REPORT: FOR PC3/CHOICE NON VA HEALTHCAREUSAspending

Company events

All 80 company events

In 12 months: 5 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
17 Aug 2026Director or officer change8-K
27 Jul 2026Director or officer change8-K
22 Jun 2026Director or officer change8-K
15 May 2026Director or officer changeSame filing: shareholder vote results8-K
24 Mar 2026Director or officer change8-K
15 Aug 2025Director or officer change8-K
4 Aug 2025Director or officer change8-K
5 Mar 2025Signed a major agreement; A major agreement endedSame filing: took on new debt8-K

Reported lobbying spend: $1.1M in Q3 2026, $1.5M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Dec 2025EndedSalt Point Strategiesfor Alb Solutions On Behalf Of Centene CorporationNot statedFiling
1 Jan 2025NewAlb Solutionsfor Centene CorporationsIssues related to health care policy including coverage and cost of care.Health issuesFiling
1 Jan 2025NewSalt Point Strategiesfor Alb Solutions On Behalf Of Centene CorporationIssues related to health care policy including coverage and cost of care.Health issuesFiling
1 Jan 2025NewWilliams And Jensen, PLLCfor Centene CorporationIssues related to Medicaid; Issues related to Medicare Advantage; Issues related to behavioral health; Issues related to prior authorization. Issues related to upcoming expiration of the Advance Premium Tax Credits (APTCs).Medicare/Medicaid, Health issuesFiling
1 Dec 2024NewContinental Strategy, LLCfor Centene CorporationStrategic guidance and counsel related to Medicare, Medicaid, and the insurance market.Health issuesFiling
30 Nov 2024EndedCornerstone Government Affairs, Inc.for Centene CorporationAdvised access to behavioral health and substance use care; Monitored Pharmacy Benefit Manager reforms; Monitored Medicare physician reimbursement; Advised and assisted with outreach to congressional offices on Affordable Care Act Marketplace enhanced advanced premium tax creditsHealth issues, Medicare/Medicaid, TaxationFiling
1 Oct 2024EndedGreenberg Traurig, LLPfor Centene CorporationLegislative monitoring on issues related to Medicare and MedicaidHealth issuesFiling
30 Sep 2024EndedHsa Strategiesfor Centene CorporationMedicare and Medicaid issuesInsuranceFiling

The 5 newest of 464 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

10 Dec 2024confirmed

Confirmed across sources Attention and Hiring and Insiders

Centene (CNC): had 24 H-1B/E-3 visa applications certified in September 2024, 3.4× the same month last year; it also drew 5,236 Wikipedia page views in the week of 2 Dec 2024, 2.7× the same week last year; and it had 4 insiders buy $1.0M of its shares on the open market within 30 days (4 filings). Three unrelated kinds of activity within 35 days.

  • Hiring: H-1B/E-3 applications change, became public on 12 Nov 2024
  • Attention: Wikipedia attention spike, became public on 10 Dec 2024
  • Insiders: Clustered insider buying, became public on 18 Dec 2024
2020-09-01: 42021-09-01: 22022-09-01: 92023-09-01: 72024-09-01: 24
September 2024 against the 4 months before it. this monthearliernormal: 5.5
See the evidence (3 changes)

Hiring: H-1B/E-3 applications change became public on 12 Nov 2024

Centene had 24 H-1B/E-3 visa applications certified in September 2024, 3.4× the same month last year.

This period
24 (September 2024)
Normal month (median of 4 earlier)
5.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+5.0
Same month last year
7
History used
1,826 days
2020-09-01: 42021-09-01: 22022-09-01: 92023-09-01: 72024-09-01: 24
September 20244 earlier monthsnormal: 5.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

Check it at the source: DOL foreign labor disclosure data.

Attention: Wikipedia attention spike became public on 10 Dec 2024

Centene drew 5,236 Wikipedia page views in the week of 2 Dec 2024, 2.7× the same week last year.

This period
5,236 (the week of 2 Dec 2024)
Normal week (median of 26 earlier)
1,769
Typical spread (median absolute deviation)
252
How far from its usual level
+9.3
Same week last year
1,921
History used
2,168 days
2024-06-03: 1,5382024-06-10: 1,5422024-06-17: 1,5392024-06-24: 1,4352024-07-01: 1,2482024-07-08: 1,4942024-07-15: 1,4612024-07-22: 1,5832024-07-29: 1,6582024-08-05: 1,5702024-08-12: 1,4492024-08-19: 1,7582024-08-26: 1,7802024-09-02: 1,5832024-09-09: 1,9922024-09-16: 1,8972024-09-23: 2,0682024-09-30: 2,1292024-10-07: 1,9082024-10-14: 2,2272024-10-21: 2,2732024-10-28: 2,0442024-11-04: 2,0422024-11-11: 2,1532024-11-18: 2,2512024-11-25: 1,9692024-12-02: 5,236
the week of 2 Dec 202426 earlier weeksnormal: 1,769

Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

Check it at the source: Wikimedia page view statistics.

Insiders: Clustered insider buying became public on 18 Dec 2024

Centene had 4 insiders buy $1.0M of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$1.0M
Window
18 Nov 2024 to 18 Dec 2024

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

11 Feb 2023confirmed

Confirmed across sources Insiders and Lobbying

Centene (CNC): lobbying on a new issue, while it had 3 insiders buy $1.5M of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 21 days.

  • Lobbying: Lobbying on a new issue, became public on 20 Jan 2023
  • Insiders: Clustered insider buying, became public on 11 Feb 2023
See the evidence (2 changes)

Lobbying: Lobbying on a new issue became public on 20 Jan 2023

Centene lobbying on a new issue.

New
['DEF']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12625423

Insiders: Clustered insider buying became public on 11 Feb 2023

Centene had 3 insiders buy $1.5M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$1.5M
Window
12 Jan 2023 to 11 Feb 2023

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

4 May 2022confirmed

Confirmed across sources Insiders and Lobbying

Centene (CNC): lobbying on a new issue, while it had 3 insiders buy $1.7M of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 13 days.

  • Lobbying: Lobbying on a new issue, became public on 21 Apr 2022
  • Insiders: Clustered insider buying, became public on 4 May 2022
See the evidence (2 changes)

Lobbying: Lobbying on a new issue became public on 21 Apr 2022

Centene lobbying on a new issue.

New
['INS']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12632158

Insiders: Clustered insider buying became public on 4 May 2022

Centene had 3 insiders buy $1.7M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$1.7M
Window
4 Apr 2022 to 4 May 2022

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 9 Oct 2026Government contracts change

    won its first award from the Department of Defense, a $3.0M contract, after 15 earlier federal awards from other agencies.

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    15

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  2. 9 Oct 2026Government contracts record

    MAGELLAN FEDERAL, INC.: new Department of Defense contract HQ003426FE315 ($3.0M) (dated 9 Jul 2026)

  3. 17 Aug 2026Filings record

    Director or officer change

  4. 30 Jul 2026Government contracts change

    booked $33.2M in federal contract and grant obligations in July 2026, against none in the same month last year.

    See the evidence
    This period
    $33.2M (July 2026)
    Normal month (median of 5 earlier)
    $861K
    Typical spread (median absolute deviation)
    $861K
    How far from its usual level
    +25.3
    Same month last year
    $0
    History used
    2,129 days
    2021-07-01: $68.7M2022-07-01: $30.1M2023-07-01: $861K2024-07-01: $02025-07-01: $02026-07-01: $33.2M
    July 20265 earlier monthsnormal: $861K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  5. 27 Jul 2026Filings record

    Director or officer change

  6. 22 Jun 2026Filings record

    Director or officer change

  7. 28 May 2026Government contracts change

    booked $40.0M in federal contract and grant obligations in May 2026, 74× its normal month.

    Same month a year earlier: -$40K.

    See the evidence
    This period
    $40.0M (May 2026)
    Normal month (median of 5 earlier)
    $538K
    Typical spread (median absolute deviation)
    $578K
    How far from its usual level
    +39.4
    Same month last year
    -$40K
    History used
    4,871 days
    2021-05-01: $443.4M2022-05-01: $538K2023-05-01: $6.1M2024-05-01: $02025-05-01: $02026-05-01: $40.0M
    May 20265 earlier monthsnormal: $538K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  8. 15 May 2026Filings record

    Director or officer change

  9. 4 May 2026Government contracts change

    booked $101.9M in federal contract and grant obligations in April 2026, against none in the same month last year.

    See the evidence
    This period
    $101.9M (April 2026)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $1.0M
    How far from its usual level
    +67.7
    Same month last year
    $0
    History used
    2,037 days
    2021-04-01: $02022-04-01: $1.4B2023-04-01: $1.0M2024-04-01: $02025-04-01: $02026-04-01: $101.9M
    April 20265 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  10. 7 Apr 2026Lobbying record

    ALB SOLUTIONS ON BEHALF OF CENTENE CORPORATION: lobbying engagement terminated (SALT POINT STRATEGIES) (dated 31 Dec 2025)

  11. 30 Mar 2026Government contracts change

    won its first award from the Department of Health and Human Services, a $13.2M contract, after 14 earlier federal awards from other agencies.

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    14

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  12. 30 Mar 2026Government contracts record

    MAGELLAN FEDERAL, INC.: new Department of Health and Human Services contract 7571MN26F66003 ($13.2M) (dated 24 Mar 2026)

  13. 24 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 24 Mar 2026Filings record

    Director or officer change

  15. 27 Aug 2025Short interest and volume change

    had 23.7M shares sold short in the 15 Aug 2025 report, 2.4× the same report last year.

    Same report last year: 9.8M; its normal report is 9.8M.

    See the evidence
    This period
    23.7M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    1.8M
    How far from its usual level
    +5.1
    Same report last year
    9.8M
    History used
    2,786 days
    2024-08-15: 9.8M2024-08-30: 10.1M2024-09-13: 9.6M2024-09-30: 7.8M2024-10-15: 8.1M2024-10-31: 14.4M2024-11-15: 15.2M2024-11-29: 16.3M2024-12-13: 19.2M2024-12-31: 8.0M2025-01-15: 5.6M2025-01-31: 6.7M2025-02-14: 9.8M2025-02-28: 6.1M2025-03-14: 9.9M2025-03-31: 7.1M2025-04-15: 10.6M2025-04-30: 8.6M2025-05-15: 10.9M2025-05-30: 7.8M2025-06-13: 9.3M2025-06-30: 9.9M2025-07-15: 13.4M2025-07-31: 27.8M2025-08-15: 23.7M
    the 15 Aug 2025 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 15 Aug 2025Filings record

    Director or officer change

  17. 12 Aug 2025Short interest and volume change

    had 27.8M shares sold short in the 31 Jul 2025 report, 2.7× the same report last year.

    Same report last year: 10.4M; its normal report is 9.8M.

    See the evidence
    This period
    27.8M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    1.7M
    How far from its usual level
    +7.1
    Same report last year
    10.4M
    History used
    2,771 days
    2024-07-31: 10.4M2024-08-15: 9.8M2024-08-30: 10.1M2024-09-13: 9.6M2024-09-30: 7.8M2024-10-15: 8.1M2024-10-31: 14.4M2024-11-15: 15.2M2024-11-29: 16.3M2024-12-13: 19.2M2024-12-31: 8.0M2025-01-15: 5.6M2025-01-31: 6.7M2025-02-14: 9.8M2025-02-28: 6.1M2025-03-14: 9.9M2025-03-31: 7.1M2025-04-15: 10.6M2025-04-30: 8.6M2025-05-15: 10.9M2025-05-30: 7.8M2025-06-13: 9.3M2025-06-30: 9.9M2025-07-15: 13.4M2025-07-31: 27.8M
    the 31 Jul 2025 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 12 Aug 2025Insiders record

    LONDON SARAH (Chief Executive Officer) bought 19,230 shares of CNC ($490,365) (dated 11 Aug 2025)

  19. 4 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 4 Aug 2025Filings record

    Director or officer change

  21. 30 Jul 2025Insiders record

    Samuels Theodore R. II (director) bought 9,000 shares of CNC ($248,580) (dated 29 Jul 2025)

  22. 8 Jul 2025Attention change

    drew 5,998 Wikipedia page views in the week of 30 Jun 2025, 4.8× the same week last year.

    Same week last year: 1,248; its normal week is 1,562.

    See the evidence
    This period
    5,998 (the week of 30 Jun 2025)
    Normal week (median of 26 earlier)
    1,562
    Typical spread (median absolute deviation)
    112
    How far from its usual level
    +22.2
    Same week last year
    1,248
    History used
    2,378 days
    2024-12-30: 1,4952025-01-06: 1,9902025-01-13: 2,2642025-01-20: 2,0172025-01-27: 2,2592025-02-03: 2,0732025-02-10: 1,6142025-02-17: 1,6752025-02-24: 1,6682025-03-03: 1,4512025-03-10: 1,5432025-03-17: 1,4572025-03-24: 1,5262025-03-31: 1,5812025-04-07: 1,3992025-04-14: 1,4142025-04-21: 1,7692025-04-28: 1,3982025-05-05: 1,3912025-05-12: 1,6292025-05-19: 1,6452025-05-26: 1,4512025-06-02: 1,6172025-06-09: 1,3862025-06-16: 1,3432025-06-23: 1,4612025-06-30: 5,998
    the week of 30 Jun 202526 earlier weeksnormal: 1,562

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  23. 5 Mar 2025Filings record

    A major agreement ended

  24. 28 Feb 2025Lobbying record

    CENTENE CORPORATIONS: new lobbying registration (ALB SOLUTIONS) (dated 1 Jan 2025)

  25. 24 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 24 Feb 2025Filings record

    Director or officer change

  27. 24 Feb 2025Lobbying record

    ALB SOLUTIONS ON BEHALF OF CENTENE CORPORATION: new lobbying registration (SALT POINT STRATEGIES) (dated 1 Jan 2025)

  28. 27 Jan 2025Lobbying record

    CENTENE CORPORATION: new lobbying registration (WILLIAMS AND JENSEN, PLLC) (dated 1 Jan 2025)

  29. 21 Jan 2025Lobbying record

    CENTENE CORPORATION: lobbying engagement terminated (CORNERSTONE GOVERNMENT AFFAIRS, INC.) (dated 30 Nov 2024)

  30. 17 Jan 2025Lobbying record

    CENTENE CORPORATION: lobbying engagement terminated (GREENBERG TRAURIG, LLP) (dated 1 Oct 2024)

  31. 17 Jan 2025Lobbying record

    CENTENE CORPORATION: new lobbying registration (CONTINENTAL STRATEGY, LLC) (dated 1 Dec 2024)

  32. 20 Dec 2024Insiders record

    Greco Thomas (director) bought 17,000 shares of CNC ($1.0M) (dated 19 Dec 2024)

  33. 18 Dec 2024Insiders change

    had 4 insiders buy $1.0M of its shares on the open market within 30 days (4 filings).

    Who bought: Blume Jessica L., Samuels Theodore R. II, Coughlin Christopher J, Dallas H James.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $1.0M
    Window
    18 Nov 2024 to 18 Dec 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  34. 18 Dec 2024Insiders record

    Dallas H James (director) bought 1,693 shares of CNC ($99,904) (dated 17 Dec 2024)

  35. 18 Dec 2024Insiders record

    COUGHLIN CHRISTOPHER J (director) bought 10,000 shares of CNC ($594,400) (dated 17 Dec 2024)

  36. 18 Dec 2024Insiders record

    Samuels Theodore R. II (director) bought 5,000 shares of CNC ($294,300) (dated 17 Dec 2024)

  37. 18 Dec 2024Insiders record

    BLUME JESSICA L. (director) bought 250 shares of CNC ($14,870) (dated 17 Dec 2024)

  38. 10 Dec 2024several at once

    had 24 H-1B/E-3 visa applications certified in September 2024, 3.4× the same month last year; it also drew 5,236 Wikipedia page views in the week of 2 Dec 2024, 2.7× the same week last year; and it had 4 insiders buy $1.0M of its shares on the open market within 30 days (4 filings). Three unrelated kinds of activity within 35 days.

    See the evidence (3 changes)

    Hiring: H-1B/E-3 applications change became public on 12 Nov 2024

    Centene had 24 H-1B/E-3 visa applications certified in September 2024, 3.4× the same month last year.

    This period
    24 (September 2024)
    Normal month (median of 4 earlier)
    5.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +5.0
    Same month last year
    7
    History used
    1,826 days
    2020-09-01: 42021-09-01: 22022-09-01: 92023-09-01: 72024-09-01: 24
    September 20244 earlier monthsnormal: 5.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

    Check it at the source: DOL foreign labor disclosure data.

    Attention: Wikipedia attention spike became public on 10 Dec 2024

    Centene drew 5,236 Wikipedia page views in the week of 2 Dec 2024, 2.7× the same week last year.

    This period
    5,236 (the week of 2 Dec 2024)
    Normal week (median of 26 earlier)
    1,769
    Typical spread (median absolute deviation)
    252
    How far from its usual level
    +9.3
    Same week last year
    1,921
    History used
    2,168 days
    2024-06-03: 1,5382024-06-10: 1,5422024-06-17: 1,5392024-06-24: 1,4352024-07-01: 1,2482024-07-08: 1,4942024-07-15: 1,4612024-07-22: 1,5832024-07-29: 1,6582024-08-05: 1,5702024-08-12: 1,4492024-08-19: 1,7582024-08-26: 1,7802024-09-02: 1,5832024-09-09: 1,9922024-09-16: 1,8972024-09-23: 2,0682024-09-30: 2,1292024-10-07: 1,9082024-10-14: 2,2272024-10-21: 2,2732024-10-28: 2,0442024-11-04: 2,0422024-11-11: 2,1532024-11-18: 2,2512024-11-25: 1,9692024-12-02: 5,236
    the week of 2 Dec 202426 earlier weeksnormal: 1,769

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

    Insiders: Clustered insider buying became public on 18 Dec 2024

    Centene had 4 insiders buy $1.0M of its shares on the open market within 30 days (4 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $1.0M
    Window
    18 Nov 2024 to 18 Dec 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  39. 10 Dec 2024Attention change

    drew 5,236 Wikipedia page views in the week of 2 Dec 2024, 2.7× the same week last year.

    Same week last year: 1,921; its normal week is 1,769.

    See the evidence
    This period
    5,236 (the week of 2 Dec 2024)
    Normal week (median of 26 earlier)
    1,769
    Typical spread (median absolute deviation)
    252
    How far from its usual level
    +9.3
    Same week last year
    1,921
    History used
    2,168 days
    2024-06-03: 1,5382024-06-10: 1,5422024-06-17: 1,5392024-06-24: 1,4352024-07-01: 1,2482024-07-08: 1,4942024-07-15: 1,4612024-07-22: 1,5832024-07-29: 1,6582024-08-05: 1,5702024-08-12: 1,4492024-08-19: 1,7582024-08-26: 1,7802024-09-02: 1,5832024-09-09: 1,9922024-09-16: 1,8972024-09-23: 2,0682024-09-30: 2,1292024-10-07: 1,9082024-10-14: 2,2272024-10-21: 2,2732024-10-28: 2,0442024-11-04: 2,0422024-11-11: 2,1532024-11-18: 2,2512024-11-25: 1,9692024-12-02: 5,236
    the week of 2 Dec 202426 earlier weeksnormal: 1,769

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  40. 14 Nov 2024Insiders record

    Asher Andrew Lynn (Chief Financial Officer) bought 17,200 shares of CNC ($1.0M) (dated 13 Nov 2024)

Showing the newest 40 of 178 entries; narrow the window or the kind of data to see older ones.

Not listed: 317 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001071739
Ticker
CNC
Domain
centene.com
Employer name
Centene Company of Texas, LP, Centene Management Company, LLC (2 unverified)
Hq location
MO|ST LOUIS|63105 (1 unverified)
Lobbying client
alb solutions on behalf of centene, centene, centene corporations
Name
Absolute Total Care, Inc, a South Carolina corporation, AcariaHealth, Inc., a Delaware corporation, AcariaHealth Pharmacy #11, Inc, a Texas corporation, AcariaHealth Pharmacy #12, Inc, a New York corporation and 243 more
Uei
NANFEH9AAH43
Wikidata
Q5059102
Wikipedia
Centene Corporation
  • DOL H-1B labor condition applications and PERM certifications1479 data points1 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)35 records, 243 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings4 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)239 records11 Jan 2016 to 26 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1107 data points31 Dec 2007 to 23 Oct 2026
  • SEC Form 4 insider transactions152 records, 440 data points5 Jan 2016 to 27 Aug 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards16 records, 2394 data points28 Jan 2013 to 19 Nov 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026